Bulwark Takes cover image

Pediatric Cancer Bill is Good News That Still Hurts

Bulwark Takes

00:00

Why pediatric cancer research lags

Sam Stein explains market incentives and why rare childhood cancers attract little pharmaceutical investment.

Play episode from 04:13
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app